Drug Profile
MV 026048
Alternative Names: MIV026048; MV-026048; MV0826048; R 1495Latest Information Update: 05 Jun 2007
Price :
$50
*
At a glance
- Originator Medivir AB
- Developer Roche
- Class
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Jun 2007 Discontinued - Preclinical for HIV infections treatment in Sweden (unspecified route)
- 05 Jun 2007 Discontinued - Preclinical for HIV infections treatment in Switzerland (unspecified route)
- 28 Dec 2005 This compound is still in active development